Table 2. Outcome for all Acute Encephalitis Syndrome patients included in the study.
| All AES patients | Confirmed JE | Other AES | Subgroups of ‘Other AES’ | P value | ||
| JE negative | JE status unknown | |||||
| Total no. of patients in each group | 72 | 22 | 50 | 31 | 19 | - |
| Died post discharge (LOS 1) | 6 (8.3) | 3 (13.6) | 3 (6.0) | 2 (6.4) | 1 (5.3) | 0.36 |
| Alive at follow-up | 66 | 19 | 47 | 29 | 18 | - |
| Any impairment at follow-up (LOS 2, 3, 4) | 32 (48.5) | 13 (68.4) | 19 (40.4) | 13 (44.8) | 6 (33.3) | 0.06 |
| Severe impairment (LOS 2) | 7 (10.6) | 4 (21.0) | 3 (6.4) | 3 (10.3) | 0 (0) | 0.10 |
| Moderate impairment (LOS 3) | 9 (13.6) | 4 (21.0) | 5 (10.6) | 3 (10.3) | 2 (11.1) | 0.27 |
| Mild impairment (LOS 4) | 16 (24.2) | 5 (26.3) | 11 (23.4) | 7 (24.1) | 4 (22.2) | 1.00 |
| No Impairment (LOS 5) | 34 (51.5) | 6 (31.6) | 28 (59.6) | 16 (55.2) | 12 (66.7) | 0.06 |
Clinical outcome for all Acute Encephalitis Syndrome patients included in the study. Outcomes presented as number in each group with proportion (%). Where outcome involved death, the denominator was based on total number of families contacted. Otherwise denominator was based on the number of patients alive at follow-up in the group. P values correspond to differences between ‘Confirmed JE’ and ‘Other AES’ groups across categories of impairment. Significance calculated using Fisher's exact test.
AES, Acute Encephalitis Syndrome; No., number; LOS, Liverpool Outcome Score (1 [died] – 5 [no impairment]).